Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
50.65B | 48.22B | 44.69B | 42.15B | 42.15B | 42.31B | Gross Profit |
17.54B | 16.30B | 15.61B | 14.81B | 12.98B | 12.74B | EBIT |
3.01B | 2.54B | 1.99B | 1.70B | 753.31M | 359.51M | EBITDA |
4.68B | 4.99B | 4.20B | 4.11B | 2.97B | 2.41B | Net Income Common Stockholders |
2.31B | 1.93B | 1.61B | 1.47B | 657.27M | 137.63M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.33B | 1.33B | 1.69B | 1.07B | 839.12M | 1.18B | Total Assets |
38.09B | 38.09B | 34.11B | 29.42B | 29.47B | 29.41B | Total Debt |
4.89B | 4.89B | 3.99B | 2.07B | 3.79B | 5.91B | Net Debt |
3.56B | 3.56B | 2.30B | 998.80M | 2.95B | 4.73B | Total Liabilities |
17.08B | 17.08B | 15.42B | 12.03B | 13.22B | 13.98B | Stockholders Equity |
20.99B | 20.99B | 18.65B | 17.35B | 16.17B | 15.35B |
Cash Flow | Free Cash Flow | ||||
0.00 | -945.03M | -404.22M | 1.91B | 2.20B | 750.46M | Operating Cash Flow |
0.00 | 2.67B | 2.45B | 2.91B | 3.57B | 3.35B | Investing Cash Flow |
0.00 | -3.55B | -2.37B | -958.78M | -1.31B | -2.50B | Financing Cash Flow |
0.00 | 457.30M | 398.44M | -2.05B | -2.36B | -2.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €448.15B | 15.92 | 9.19% | 1.70% | 5.92% | 56.91% | |
74 Outperform | $1.30T | 20.73 | 12.17% | 1.76% | 7.29% | 9.77% | |
74 Outperform | ¥3.41T | 48.92 | 8.89% | 1.11% | 8.76% | -0.23% | |
73 Outperform | ¥265.75B | 20.68 | 4.20% | 1.69% | 6.21% | -25.51% | |
69 Neutral | €466.20B | 18.90 | 9.55% | 2.54% | 3.70% | 0.75% | |
64 Neutral | $8.82B | 14.56 | 4.78% | 173.92% | 3.50% | 2.20% | |
62 Neutral | ¥31.66B | 14.38 | 1.49% | 7.17% | 45.25% |